The principals of IGBS, have more than forty years of combined experience commercializing medical products. Our work spans the entire gamut of commercial development, from preclinical business and regulatory planning to clinical validation and the management of pivotal clinical trials leading to FDA approval. IGBS has the expertise and integrated network to effectively manage all phases of the biotechnology commercialization process. Our project management approach to clinical development provides our clients with the flexibility of selecting the appropriate development partners. IGBS does not have the overhead costs associated with traditional clinical development organizations. And whether you are looking for Pharmacology and Toxicology testing or Strategic Regulatory Support, our affiliated network allows us to engage professionals with specific product and disease state expertise on your behalf. We have experience in the fields of cancer, infectious diseases, molecular and antibody based diagnostics, immunotherapy based biologics, and medical devices. We also understand how to obtain extramural funding for biotechnology based product development projects; including SBIR grants and the development of proposals for private equity investment. We have experience working with major pharmaceutical companies as well as early-stage ventures. Coming from successful start-up organizations, we understand the unique needs of early-stage organizations and the importance of having clear development objectives delivered accurately, on time and on budget.